IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.32 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5,163,626 | -29.0% | 125,850 | -38.1% | 0.01% | -38.9% |
| Q1 2023 | $7,271,874 | +26.3% | 203,466 | +30.8% | 0.02% | -5.3% |
| Q2 2022 | $5,758,000 | -58.5% | 155,533 | -65.9% | 0.02% | -59.6% |
| Q4 2021 | $13,865,000 | -2.0% | 455,620 | +8.0% | 0.05% | -20.3% |
| Q3 2021 | $14,154,000 | -28.9% | 422,015 | -15.4% | 0.06% | -37.2% |
| Q2 2021 | $19,896,000 | +684.5% | 498,786 | +1012.2% | 0.09% | +571.4% |
| Q4 2020 | $2,536,000 | -83.3% | 44,848 | -82.3% | 0.01% | -86.5% |
| Q3 2019 | $15,173,000 | +432.6% | 253,265 | +344.3% | 0.10% | +700.0% |
| Q3 2018 | $2,849,000 | -78.4% | 57,000 | -78.3% | 0.01% | -68.3% |
| Q4 2017 | $13,204,000 | +27.0% | 262,500 | +28.0% | 0.04% | 0.0% |
| Q3 2017 | $10,399,000 | +1381.3% | 205,100 | +1386.2% | 0.04% | +1266.7% |
| Q2 2017 | $702,000 | -89.5% | 13,800 | -90.1% | 0.00% | -91.7% |
| Q4 2016 | $6,696,000 | -41.9% | 140,000 | -24.7% | 0.04% | -55.0% |
| Q4 2015 | $11,516,000 | – | 185,954 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |